Less than a week after Novartis unveiled a plan to establish a “flagship manufacturing hub” in North Carolina that would add 700 employees to its rolls, the Swiss drugmaker says it is making moves in ...

It earned FDA approval for a spinal muscular atrophy drug. This is a version of its existing commercialized SMA treatment, Zolgensma. Novartis announced late Monday that the U.S. Food and Drug ...

Novartis has received an FDA approval for Itvisma, a new version of the company’s gene therapy Zolgensma, to treat older patients with spinal muscular atrophy (SMA). The approval comes more than six ...

Nov 24 (Reuters) - (This Nov 24 story has been corrected to fix the pricing for Zolgensma to $2.5 million from $2.1 million in paragraph 4) The U.S. Food and Drug Administration has approved Novartis' ...

ZURICH, Nov 25 (Reuters) - Novartis (NOVN.S), opens new tab said on Tuesday that it plans to cut up to 550 full-time jobs by the end of 2027 at one of the Swiss pharmaceutical firm's sites in ...

As Thanksgiving is upon us, millions of Americans are getting ready to cook mountains of food and trying new recipes, but beware, as food recalls for contaminated products are currently underway.

Honda is recalling more than 256,000 vehicles because of electrical issues, according to the National Highway Traffic Safety Administration. For a full list of vehicles or to find out of your car ...

The National Highway Traffic Safety Administration issued multiple recalls for vehicles last week, including notices for over 140,000 Hyundai vehicles. Are you looking to see if recalls have been ...

Two products sold by Walmart — one of which had also been available on Amazon.com — are being recalled over potential safety issues, according to joint notices published Wednesday by the U.S. Consumer ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is moving fast with ...

Novartis secured approval for its drug to treat certain patients diagnosed with spinal muscular atrophy from the Food and Drug Administration. Itvisma, or onasemnogene abeparvovec-brve, was approved ...

Jani Hall is a news editor for Health with a background in health and science journalism. Previously, she worked as a staff reporter for National Geographic. A recall is underway for certain gallons ...